Search results

From WikiMD.com Medical Encyclopedia

  • ...velopment of dalcetrapib was discontinued due to lack of efficacy in major clinical trials. ==Clinical Trials and Discontinuation==
    3 KB (452 words) - 18:16, 18 April 2024
  • ==Development and Clinical Trials== ...ow to the heart. Clinical trials for otamixaban included the phase III TAO trial (Treatment of Acute coronary syndrome with Otamixaban), which compared otam
    3 KB (395 words) - 14:00, 20 April 2024
  • ==Clinical Uses== ...here, outlining common, less common, and rare adverse effects reported in clinical trials or post-marketing surveillance. This would also include any known co
    3 KB (420 words) - 14:13, 21 April 2024
  • ...eutics|access-date=2019-04-26}}</ref> Riosertib is in [[phase III clinical trial]]s for the treatment of [[chronic myelomonocytic leukemia]].<ref>https://cl [[Category:Antineoplastic and immunomodulating drug stubs]]
    2 KB (254 words) - 05:07, 25 February 2024
  • * '''[[American College of Clinical Pharmacology]]''' * '''[[American College of Clinical Pharmacy]]'''
    256 KB (34,162 words) - 00:11, 7 November 2023